0001593968-18-001323.txt : 20181009
0001593968-18-001323.hdr.sgml : 20181009
20181009160309
ACCESSION NUMBER: 0001593968-18-001323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181004
FILED AS OF DATE: 20181009
DATE AS OF CHANGE: 20181009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Colangelo Dominick
CENTRAL INDEX KEY: 0001313403
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 181113664
MAIL ADDRESS:
STREET 1: 1000 WINTER ST.
STREET 2: SUITE 2200
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2018-10-04
0000887359
Vericel Corp
VCEL
0001313403
Colangelo Dominick
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
true
true
false
false
President and CEO
Common Stock
2018-10-04
4
M
false
75000
1.95
A
150163
D
Common Stock
2018-10-04
4
S
false
75000
15.02
D
75163
D
Stock Option (right to buy)
1.95
2018-10-04
4
M
false
75000
0
D
2026-02-09
Common Stock
75000
72188
D
The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018.
These options, representing the right to purchase a total of 165,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on May 9, 2016, which was one quarter after the date on which the option was granted.
/s/ Dominick C. Colangelo
2018-10-09